Hot Stocks to Watch: Annaly Capital Management, Inc. (NYSE:NLY), Novavax, Inc. (NASDAQ:NVAX)

Annaly Capital Management, Inc. (NYSE:NLY)

The shares of Annaly Capital Management, Inc. (NYSE:NLY) started off the last trading session with the price of $10.34 while closing the day with the price of $10.34. The shares of Annaly Capital Management, Inc. (NYSE:NLY) Rise 0.19% with the Gain of 0 points.

The shares of Annaly Capital Management, Inc. (NYSE:NLY) traded with the day volume of 4.62 Million shares whereas its average trading volume is 9.15 Million.

While analyzing the past performance of the stock we can see that the shares of Annaly Capital Management, Inc. (NYSE:NLY) Gain 2.17% in the last week while rising 1.27% in the last month. Past quarter performance shows the red light with -13.47%. The semi-annual and annual performance shows -16.21% and -3.63% respectively.

Some critical values of the shares of Annaly Capital Management, Inc. (NYSE:NLY) to be discussed here are: the beta which shows the value at 0.14 while Average True Range of Annaly Capital Management, Inc. (NYSE:NLY) demonstrate the value at 0.2. The weekly and monthly volatility of the shares of Annaly Capital Management, Inc. (NYSE:NLY) are indicated at 1.40% and 1.84%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 46.27.

While studying the financial position of the shares of Annaly Capital Management, Inc. (NYSE:NLY), we can see that the Market capitalization of the company is at 11.97 Billion. The shares outstanding for the company is 1.16 Billion and the shares float stands at 1.16 Billion. The income of the company stand at 1.46 Billion while the sales stand at 2.81 Billion.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 1.33, Price to Earnings or P/E is at 7.75, Price to Sales P/S show the value of 4.26, the Return on Asset ROA stood at 0.016 and the Return on Equity ROE depicted at 0.121 while Return on Investment ROI is at 0.016.


Novavax, Inc. (NASDAQ:NVAX)

Novavax, Inc. (NASDAQ:NVAX) started its previous trading session at $2.05 and closed at $2.06 showing a Rise of 0.98 Percent.

The Company traded with an average Volume of 12.1 Million whereas, its Day Volume stood at 4.61 Million.

Looking at the performance of the stock, Novavax, Inc. (NASDAQ:NVAX) Loss -3.74% in the last week in its shares price and -1.44% in the last month. Quarterly performance shows a green of 45.07 Percent while Semi-Annual and Annual performances shows a 74.58 and 41.1 percent respectively.

Beta for Novavax, Inc. (NASDAQ:NVAX) stands at 2.4 while the ATR (average true range) is at 0.18. The Stock’s Weekly and Monthly Volatility is 5.42% and 8.65% respectively showing a RSI value of 51.15.

While studying the financial position of the shares of Novavax, Inc. (NASDAQ:NVAX), we can see that the Market capitalization of the company is at 639.79 Million. The shares outstanding for the company is 310.58 Million and the shares float stands at 309.38 Million.

The Company generated an income of -190000000 and the sales of 26.2 Million in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-0.68 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 24.42 respectively.

The Return on Assets stands at -0.526, ROE shows a value of 4.528 and ROI for Novavax, Inc. (NASDAQ:NVAX) is 0 as of Trailing Twelve Months period.

The following two tabs change content below.

Eldred Matthew

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Comment